Physician profile
Kunal Patel
NPI 1548600240
$8,699.14
in general payments reported to CMS, 2019-2025
23 companies · $761 in 2025
The $761 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.16 · 2020: $49.99 · 2021: $202 · 2022: $3,704 · 2023: $3,589 · 2024: $374 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,724.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,043.69 | 2022-2023 | Da Vinci Surgical System |
| Genzyme Corporation | $796.93 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $402.32 | 2021-2025 | Dupixent |
| Grifols USA, LLC | $189.38 | 2023-2024 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $174.33 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $151.62 | 2022-2025 | Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $151.55 | 2022-2025 | Nucala |
| Philips North America LLC | $135.73 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $57.64 | 2025 | Glassia |
| Insmed, INC. | $57.63 | 2024-2025 | Arikayce |
| Electromed, INC. | $56.91 | 2021-2025 | Smartvest |
| Viatris Specialty LLC | $54.00 | 2025 | Yupelri |
| Abiomed | $49.99 | 2020 | |
| Amgen INC. | $38.67 | 2022-2025 | Tezspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $28.71 | 2022 | |
| Verona Pharma, INC. | $24.64 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $21.57 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Genentech USA, INC. | $21.28 | 2022 | |
| Baxter Healthcare | $20.84 | 2022 | |
| Lilly USA, LLC | $20.44 | 2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $17.78 | 2021 | |
| Medical Graphics Corporation | $16.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.